Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

Are peptides legal in Idaho?

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

The short answer

Yes. An Idaho resident can obtain FDA approved peptides such as semaglutide and tirzepatide by prescription from an Idaho-licensed provider, including through virtual care under the Idaho Virtual Care Access Act (Idaho Code 54-5701 and following), which lets a provider-patient relationship be established through virtual care technologies if the Idaho community standard of care is met. Compounded peptides are available when eligible under federal 503A rules and dispensed by an Idaho pharmacy or a nonresident drug outlet registered with the Idaho State Board of Pharmacy under Idaho Code 54-1729. Treatment based solely on a static online questionnaire is not acceptable in Idaho.

Regulatory: Telehealth allowedRegulatory: Async allowedRegulatory: Compounded GLP-1 limitedVerified: Verified Oct 28, 2026
Compounding rules
Follows the federal 503A framework
Telehealth prescribing
Allowed, asynchronous allowed; a questionnaire alone is not enough
Compounded GLP-1
Limited

Can a Idaho resident get peptides by telehealth?

The Idaho Virtual Care Access Act (Idaho Code Title 54, chapter 57, rewritten in 2023) defines virtual care as an umbrella term covering synchronous and asynchronous care delivery modalities (54-5703). Idaho Code 54-5705 lets a provider deliver virtual care when the provider has first established a relationship with the patient, another provider in the provider group has one, the provider is covering calls for a provider who does, or an exception listed in 54-1733(3) applies, and states that a provider-patient relationship may be established by use of virtual care technologies, provided the applicable Idaho community standard of care is satisfied. Section 54-5706 requires the provider to obtain and document relevant clinical history and current symptoms before issuing a prescription drug order, and states that treatment based solely on a static online questionnaire does not meet the standard of care. Section 54-5707 allows prescribing by virtual care within the provider's scope of practice; controlled substances must comply with federal law. Idaho Code 54-5713 (added 2023) requires a provider to hold a license from the applicable Idaho board before delivering virtual care, with narrow exceptions for a provider licensed in another state who already has a relationship with a patient temporarily in Idaho, is giving short-term follow-up for continuity of care, is employed by or contracted with an Idaho facility, is responding to a disaster, is preparing for a scheduled in-person visit, or is consulting with or referring to an Idaho-licensed provider. A direct-to-consumer telehealth program run from another state generally fits none of these exceptions, so its prescriber needs an Idaho license, and an exempt provider consents to Idaho law, the Idaho community standard of care, and Idaho board jurisdiction. This record classifies asynchronous prescribing as allowed because the Act names asynchronous modalities as virtual care and lets both the relationship and the prescription come through virtual care with no real-time requirement; a static questionnaire alone is not enough. [2] [3] [4] [5] [6] [7] [9]

How does the Idaho pharmacy board treat compounding?

Compounding regulator for Idaho
BoardIdaho State Board of Pharmacy (Division of Occupational and Professional Licenses)
Eligible substancesFollows the federal 503A framework

The Idaho State Board of Pharmacy, administered by the Division of Occupational and Professional Licenses, regulates compounding under the Idaho Pharmacy Act (Idaho Code Title 54, Chapter 17). In 2025, House Bill 200 moved the Board's rules into statute and IDAPA 24.36.01, including its former compounding section 24.36.01.700, ceased to have effect on July 1, 2025. Compounding standards now sit in Idaho Code 54-1765 through 54-1767: section 54-1765 treats any compounding it does not permit as manufacturing, requires active ingredients from an FDA registered manufacturer with a certificate of analysis unless the ingredient meets a USP-NF monograph, prohibits compounding drugs FDA has identified as demonstrably difficult to compound or withdrawn from the market, limits copies of commercially available products, and requires policies that take into account USP chapters 795 and 797; section 54-1766 covers sterile preparation. Idaho's pharmacy law is shorter than most, but eligibility of a peptide for compounding still follows the federal 503A framework (approved drug component, USP or NF monograph, or FDA 503A bulks list). Under Idaho Code 54-1729, every drug outlet doing business in or into Idaho must be licensed or registered, a nonresident pharmacy must be licensed in good standing in its home state with a registered person in charge, and the Board may inspect a nonresident outlet at the outlet's expense if its home state will not. [1] [8] [10] [11] [12] [13]

Can you get compounded GLP-1s in Idaho?

Regulatory: Compounded GLP-1 limited

Branded Wegovy, Zepbound, Ozempic, and Mounjaro are available from Idaho pharmacies by prescription. Idaho's virtual care law generally requires the provider to hold an Idaho license (Idaho Code 54-5713). It lets the provider form the relationship and prescribe through virtual care, including asynchronous care, when the Idaho community standard of care is met (54-5703, 54-5705, 54-5707). Treatment based solely on a static online questionnaire is not acceptable (54-5706). Patients should confirm an out-of-state pharmacy is registered as a nonresident drug outlet with the Idaho Board. [2] [3] [4] [5] [8] [9] [16]

Prices by channel: semaglutide cost, tirzepatide cost.

Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.

What is the legal access path in Idaho?

Access options

We may earn a commission from these links.

Prices are the partner's own and are not verified by PeptideAgent. You answer health questions after checkout, and the partner's clinician decides whether to prescribe.

Unsponsored access paths are checked against public regulatory records. Sponsored offers are the partner's and are labeled. Products labeled research use only are never listed.

Find a provider in Idaho

What you'll actually find in Idaho, and how to check

Licensed compounding pharmacies, clinics, and telehealth prescribers openly offer many unapproved peptides, and prescribers write prescriptions for them. [20] [21] [22]

No FDA oversight of the specific product: FDA does not check a compounded drug's safety, effectiveness, or quality before it is sold. [23]

What Idaho has done

PeptideAgent has not found a board or legislative action on peptides in Idaho.

Other states have acted:

  • On August 19, 2026, Mississippi's medical, nursing, and pharmacy boards said no licensed provider may prescribe, recommend, supply, or administer a peptide that is not FDA approved, and that a consent form does not remove the provider's liability. [25] Mississippi law
  • Louisiana acted by statute: Act 374, in effect August 1, 2026, bars its licensing boards from prohibiting peptides only when they come from a pharmacy or outsourcing facility that complies with federal compounding law. It does not make any peptide eligible to compound. [26] [27] Louisiana law

Checking the prescriber

Telehealth prescribing of non-controlled peptides is permitted in Idaho. A prescriber may prescribe without a live visit (asynchronous care) when it meets the standard of care. State law says an online questionnaire alone is not enough. [2] [3] [4] [5] [6] [7] [9] The telehealth rule in full.

Checking the pharmacy

Look the pharmacy up yourself before you pay, including an out-of-state mail-order pharmacy. The pharmacy regulator is the Idaho State Board of Pharmacy (Division of Occupational and Professional Licenses); its license search: FDA BeSafeRx: state board of pharmacy license lookups. [24]

If you're going ahead anyway

These steps lower some risks. They do not make a compounded product safe, and FDA has not reviewed it. [23]

They do not change a peptide's legal status either. That depends on the peptide: for a withdrawn nomination such as BPC-157 or TB-500, a 503A pharmacy has no federal basis to compound it from bulk, with or without a prescription, while a few Category 1 substances, such as NAD+ and glutathione, are compounded under FDA's interim policy, with conditions. Each peptide page gives its status. [14] [28] [29]

Check the pharmacy's license. Look the pharmacy up yourself on your state board of pharmacy's license search; FDA's BeSafeRx page links every state's. If the pharmacy is not listed, or is not licensed in your state, do not use it. [24] [30] [31]

What a legitimate prescription and consult look like. Federal law lets a pharmacy compound only for an identified patient on a valid prescription. A legitimate prescriber is licensed in the state where you are, evaluates you, and tells you the drug is compounded and not FDA approved, and a telehealth company should say which pharmacy compounds it. A seller that needs no prescription, or a pharmacy with no pharmacist to answer questions, is a warning sign. [22] [31] [32]

Why this is safer than a research-use-only product. A state-licensed pharmacy answers to its state board and has a pharmacist you can reach. A product labeled "research use only" or "not for human consumption" has neither, and FDA treats such products sold for people as unapproved drugs. In a 2024 study of semaglutide sold online without a prescription, half of six orders never arrived, and every vial that did was rated probably substandard or falsified, held more drug than its label said, and contained endotoxin. Black-market growth peptides have also contained modified molecules the label did not name. Safer is not safe: compounded drugs can also be contaminated or have too much or too little active ingredient. [23] [33] [34] [35] [36] [37]

Check for:

  • A 503A pharmacy licensed in your state (your state board of pharmacy publishes license lookups). [23]
  • A real evaluation by a licensed prescriber, not just an online form.
  • A certificate of analysis for the specific batch.

Questions to ask

  • Pharmacy: What is your license number, and are you licensed in my state? Then check it yourself on the state board's site. [24]
  • Telehealth company: Which pharmacy compounds and ships this, and is it a 503A pharmacy or a 503B outsourcing facility? [22]
  • Pharmacy: Is this made for me on a prescription written in my name? [32]
  • Prescriber: Are you licensed where I am, and will you evaluate me yourself rather than rely on a questionnaire? [22] [31]
  • Anyone offering it: Does anyone call it "FDA approved", "generic", or from an "FDA-approved pharmacy"? None of these is true of a compounded drug, so the claim is a red flag. [22]

What is offered for a specific peptide, and what FDA found, is on each peptide page.

Is it legal to buy research peptides in Idaho?

Idaho Code 54-1729 requires every drug outlet doing business in or into Idaho to be licensed or registered with the Board of Pharmacy. "Research use only" peptides sold for human injection are unapproved new drugs under federal law regardless of labeling, are not dispensed by a pharmacist, and do not become lawful because Idaho's pharmacy rules are comparatively light. [8] [17]

Peptide-specific notes for Idaho

Peptide-specific notes for Idaho
PeptideNote
SemaglutideAvailable branded by prescription, including through virtual care where the relationship is formed with virtual care technologies under Idaho Code 54-5705. Compounded semaglutide is limited to documented patient-specific needs since the 503A grace period ended April 22, 2025. [2] [16]

Frequently asked questions

Can I get a GLP-1 prescription in Idaho without a video visit?

Yes, if the Idaho community standard of care is met. The Idaho Virtual Care Access Act counts asynchronous care as virtual care (Idaho Code 54-5703), lets a provider-patient relationship be established by virtual care technologies (54-5705), and lets that provider prescribe by virtual care (54-5707). A static online questionnaire alone is not acceptable, and the provider must document your clinical history and current symptoms (54-5706). [2] [3] [4] [5] [7]

What does an out-of-state pharmacy need to ship compounded peptides to Idaho?

Registration as a nonresident drug outlet with the Idaho State Board of Pharmacy under Idaho Code 54-1729, a home-state license in good standing, and a registered person in charge. Check the Division of Occupational and Professional Licenses lookup before ordering. [1] [8]

Does Idaho's lighter pharmacy rulebook mean more peptides can be compounded there?

No. Idaho's compounding statute, Idaho Code 54-1765, sets quality standards but does not create a state list of allowed substances, so eligibility still follows the federal 503A test, and peptides in FDA Category 2 cannot be compounded. [10] [13] [14]

Can an Idaho pharmacy compound BPC-157?

Only under a draft federal policy, and only within strict limits. On October 28, 2026 HHS released a draft enforcement discretion policy saying it will not take enforcement action against a state-licensed pharmacy that compounds BPC-157 as a single-ingredient product by an allowed route, on a patient-specific prescription, from an FDA-registered manufacturer's substance with a tested certificate of analysis, with serious adverse events reported to FDA. BPC-157 is still not FDA approved or on the 503A bulks list, the policy is not binding and HHS may revisit it, and blends such as Wolverine are not covered. FDA's drug center recommended against listing BPC-157; the advisory committee voted in favor (HHS policy, Appendix B). State law still applies: Idaho does not create a state list of allowed substances, so eligibility still follows the federal 503A framework. [13] [14] [15] [18] [19]

Sources

Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, federal FDA guidance, and the FDA warning letters and studies behind what is offered.

  1. [1]Idaho State Board of Pharmacy, Division of Occupational and Professional Licenses
  2. [2]Idaho Code 54-5705, Provider-patient relationship (Idaho Virtual Care Access Act)
  3. [3]Idaho Code 54-5703, Definitions (Idaho Virtual Care Access Act)
  4. [4]Idaho Code 54-5706, Evaluation and treatment (Idaho Virtual Care Access Act)
  5. [5]Idaho Code 54-5707, Prescriptions (Idaho Virtual Care Access Act)
  6. [6]Idaho Code 54-1733, Validity of prescription drug orders
  7. [7]Idaho Code Title 54, Chapter 57, Idaho Virtual Care Access Act
  8. [8]Idaho Code 54-1729, Registration and licensure of facilities (drug outlets, including nonresident)
  9. [9]Idaho Code 54-5713, Virtual care licensure exemptions and jurisdiction consent
  10. [10]Idaho Code 54-1765, Compounding drug preparations, general provisions (added 2025)

Cite this page

Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.

APA style
PeptideAgent. (2026, October 28). Are peptides legal in Idaho?. https://peptideagent.ai/legal/idaho
HTML link
<a href="https://peptideagent.ai/legal/idaho">Are peptides legal in Idaho?</a>, PeptideAgent, updated October 28, 2026.